GlassScriptPhysician profile
Dereck D Totten
NPI 1457795635
$1,445.89
in general payments reported to CMS, 2019-2025
21 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $39.91 · 2021: $246 · 2022: $254 · 2023: $222 · 2024: $230 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $438.41 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $224.46 | 2021-2025 | Teflaro, Vraylar, Qulipta |
| Novartis Pharmaceuticals Corporation | $178.20 | 2019-2025 | |
| Lilly USA, LLC | $77.55 | 2021-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $62.85 | 2022 | |
| Novo Nordisk INC | $62.24 | 2019-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $57.15 | 2019-2024 | Breztri |
| Glaxosmithkline, LLC. | $52.99 | 2022-2023 | Pediarix, Bexsero, Arexvy |
| Dexcom, INC. | $42.93 | 2022-2023 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $31.80 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $29.94 | 2021 | |
| Astellas Pharma US INC | $26.71 | 2023 | Veozah |
| Ge Healthcare | $26.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.97 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $16.97 | 2023 | |
| Grifols USA, LLC | $16.91 | 2024 | Prolastin-C Liquid |
| Exact Sciences Corporation | $15.04 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $14.24 | 2023 | Freestyle Libre 2 |
| Pfizer INC. | $11.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dereck Totten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.